Literature DB >> 3750366

Effects of development, aging, and renal and hepatic insufficiency as well as hemodialysis on the plasma concentrations of albumin and alpha 1-acid glycoprotein: implications for binding of drugs.

G M Pacifici, A Viani, G Taddeucci-Brunelli, G Rizzo, M Carrai, H U Schulz.   

Abstract

The concentrations of total proteins, albumin, alpha 1-acid glycoprotein (AGP), and nonesterified fatty acids (NEFA) were measured in the serum of 21 newborn infants and 13 children, aged 1-13 months, and in the plasma of 31 volunteers, 25 patients with renal failure, 27 patients with cirrhosis, 39 uremic patients undergoing hemodialysis, and 20 elderly subjects. The concentration of albumin in the volunteers was higher than in all other groups. The concentration of AGP in the volunteers was higher than in newborn infants but lower than in elderly subjects, patients with renal failure, and those with chronic uremia. The concentration of NEFA in volunteers was higher than in newborn infants and patients with renal failure and lower than in elderly subjects and patients with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3750366     DOI: 10.1097/00007691-198609000-00003

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  23 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

2.  The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function.

Authors:  G Everson; K C Lasseter; K E Anderson; L A Bauer; R L Carithens; K D Wilner; A Johnson; R J Anziano; T A Smolarek; R Z Turncliff
Journal:  Br J Clin Pharmacol       Date:  2000       Impact factor: 4.335

Review 3.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 4.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

Review 5.  Therapeutic drug monitoring in pregnancy: rationale and current status.

Authors:  C Knott; F Reynolds
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

6.  The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment.

Authors:  A Viani; G Rizzo; M Carrai; G M Pacifici
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

Review 7.  Measurement and analysis of unbound drug concentrations.

Authors:  J D Wright; F D Boudinot; M R Ujhelyi
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

Review 8.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

9.  Plasma protein binding of alpidem in healthy volunteers, in neonates and in liver or renal insufficiency.

Authors:  G M Pacifici; G Bianchetti; A Viani; G Rizzo; M Carrai; J Allen; P L Morselli
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

10.  The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.

Authors:  F Aweeka; D Jayesekara; M Horton; S Swan; L Lambrecht; K D Wilner; J Sherwood; R J Anziano; T A Smolarek; R Z Turncliff
Journal:  Br J Clin Pharmacol       Date:  2000       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.